Bristol-Myers Squibb Announces $40 Billion Investment Plan to Expand U.S. Operations Over Next Five Years

Gelonghui May 6 | U.S.-based pharmaceutical company Bristol-Myers Squibb is preparing to invest $40 billion in the United States over the next five years to expand its operations. According to CEO Christopher Boerner, the investment will include accelerating the research and development of new drugs, enhancing technological capabilities, and establishing manufacturing facilities in the U.S. However, Boerner did not specify whether this investment is new or part of a previously announced total plan. Earlier on Monday, U.S. President Trump signed an executive order directing relevant departments to streamline the approval processes required for pharmaceutical companies to set up manufacturing plants in the U.S., with the aim of boosting domestic drug production.